Practice Management News

Burnout has been added to the 11th revision of the International Classification of Diseases as a legitimate medical syndrome, according to a news release.

Opening arguments were slated to start Tuesday, May 28, in the second opioid lawsuit that the state of Oklahoma has brought against an opioid manufacturer, according to a press release from the Oklahoma attorney general’s office.

WASHINGTON — The FDA’s Office of Prescription Drug Promotion uses many methods to assess the validity of a potential medication’s print advertising, labels and other such materials for a particular medication before the agency can clear the materials for public marketing, an employee within the agency’s office that oversees that variable process said.

WASHINGTON — Federal regulations regarding data privacy and collection may lead to the United States falling behind countries like China in developing artificial intelligence and neural networks for healthcare, a speaker said here.

WASHINGTON — Following nearly 2 years under the leadership of Commissioner Scott Gottlieb, MD, the FDA and its Acting Commissioner Norman E. Sharpless, MD, will continue to enact Gottlieb’s action plans in 2019 and keep an eye on potential challenges as the country moves toward the 2020 presidential election, a speaker said here.

The Justice Department brief filed on May 1 amounts to the Trump administration picking and choosing what parts of the Affordable Care Act should stay in place and also suggests it does not understand the law, experts told Healio Primary Care Today.

Medical errors are common and are the third-leading cause of death in the United States, accounting for more than 250,000 deaths per year, according to researchers from Johns Hopkins Medicine.

Patients’ social determinants of health were determined in 1 minute with a short survey, according to findings recently published in Annals of Family Medicine.

A coalition of states allege a string of drug companies arranged a scheme that would raise generic drug prices in some instances by more than 1,000% and reduce competition for generic drugs, according to a recent press release from the New Jersey Attorney General’s Office.

PHILADELPHIA — There are several plants besides marijuana that may fill the growing need for nonpharmaceutical alternatives to pain relief that many medical professionals and patients seek, a speaker at the American Academy of Neurology Annual Meeting said.